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Syncope and electrocardiographic suspicion  
of acute anterior ST-elevation myocardial infarction  
— think about Brugada syndrome!
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z uniesieniem odcinka ST nad ścianą przednią — pomyśl o zespole Brugadów!
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Abstract
This is a case of a 52-year-old male after an episode of syncope and with atypical chest pain referred to the hospital 
with acute anterior ST-elevation myocardial infarction. Urgent coronary angiography showed normal coronary arteries 
and only an electrocardiogram (ECG) made the next day induced to suspect Brugada syndrome. The patient had im-
plantable cardioverter-defibrillator implanted and because of the high defibrillation threshold, subcutaneous electrode 
implantation was decided. The present case highlights that ECG changes in Brugada syndrome can mimic ST elevation 
in the course of the acute coronary syndrome and that subcutaneous electrode implantation may be a useful method 
of lowering the defibrillation threshold.
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Introduction
We present a patient after syncope, in whom initial exa-
mination and electrocardiogram (ECG) suggested acute 
coronary syndrome (ACS) with elevated ST-segment but the 
final diagnosis was Brugada syndrome (BrS).
Case report
A 56-year-old male was admitted to the hospital after syn-
cope, which occurred without any prodromal symptoms, 
during a walk. His history revealed frequent episodes of pal-
pitation and atypical chest pain, but no previous syncope. 
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Since childhood, he was treated for asthma with inhaled 
corticosteroids and beta2 agonists. For a few days before 
admission to the hospital, he had suffered from an upper 
respiratory tract infection with fever and he escalated the 
frequency of inhaled drugs. There was no family history of 
sudden cardiac death.
On admission he was conscious, Glasgow Coma Scale 
(GCS) 15 points, vital signs within normal limits. He com-
plained about atypical chest pain. Electrocardiogram (ECG) 
showed ST elevation in V1–V3 leads. When intracranial 
bleeding was excluded in the head computed tomography 
(CT) scan, the patient was qualified for urgent coronary an-
giography, which showed normal coronary arteries. Echo-
cardiography didn’t reveal any abnormalities. Apart from 
elevated C-reactive protein (CRP), there were no other ab-
normalities in laboratory tests.
During the next days repeated ECG records revealed 
changes typical for BrS (Figure 1A–C), so the patient was 
261www.journals.viamedica.pl/folia_cardiologica
Małgorzata Wojciechowska et al., ST-elevation myocardial infarction and Brugada syndrome
qualified for implantable cardioverter-defibrillator (ICD) im-
plantation. As the defibrillation test revealed a high defibril-
lation threshold (DT), the patient underwent subcutaneous 
electrode implantation (Figure 2) and in the second defibril-
lation test, DT became acceptable. The patient has been 
remotely monitored (CareLink) and in two years’ follow-up, 
any arrhythmic episode was recorded.
Discussion
BrS is a rare disorder inherited in an autosomal dominant 
manner. There is a tendency to severe ventricular arrhyth-
mia and the first sign of the disease may be sudden cardiac 
death [1]. The diagnosis is based on characteristic ECG 
features (type 1 pattern, ≥ 2 mm ST-segment elevation in 
lead V1 and/or V2, Figure 1C), which have high dynamici-
ty, can appear temporarily and change in time [1, 2]. We 
can diagnose BrS when these ECG changes occur either 
spontaneously or appear during provocative drug tests with 
sodium-channel blockers. Lethal arrhythmias usually occur 
during rest or sleep, which suggests an association with 
increased parasympathetic tone. Triggers, that unmask 
ECG type 1 pattern are also some drugs, fever, excessive 
alcohol intake and large meals [1, 3]. Pathophysiology 
refers to right ventricular outflow tract (RVOT) and ion 
channel dysfunction, however, increased fibrosis and 
decreased expression of gap junction in RVOT has also 
been hypothesized [1, 4]. The current main therapy is ICD 
implantation indicated in symptomatic patients (resusci-
tated sudden cardiac arrest or syncope) [5], but catheter 
ablation has been recently reported as a new treatment 
[4]. In patients with spontaneous type 1 pattern but without 
any symptoms, the electrophysiological test can be used 
to assess the need for ICD [5].
Due to possible significant adverse events, routine DT 
testing is no longer recommended in all patients at the 
time of ICD implantation [6]. However, it is reasonable to 
perform the test, if there are risk factors for high DT, like 
young age, high body mass index, non-ischemic cardiomy-
opathy or congenital heart diseases [6, 7]. In the present 
case, the DT test was performed due to the increased risk 
of high DT in patients with inherited channelopathies.
Many laboratory, clinical and echocardiographic fac-
tors that increase the risk of high DT have been identi-
fied, some of them may be reversible and easy to elimi-
nate [7]. Subcutaneous electrode implantation is the 
method of lowering DT that is used, when (like in this 
case) the reason for high DT is irreversible or cannot be 
eliminated [7, 8].
As mentioned before, fever is a strong factor causing 
changes in the ECG and leading to dangerous arrhythmias 
in the course of BrS [3]. The patient was instructed about 
the rapid relief of any fever and for 2 years any arrhythmic 
episode has been recorded.
Conclusions
The present case highlights that ECG changes in BrS can 
mimic ST elevation in the course of ACS. Furthermore, 
a coincidence of ST elevation in V1–V3 and syncope should 
direct one’s thinking towards BrS, even if ECG changes are 
not typical, as they are very dynamic and may even con-
ceal temporarily [2]. According to a recommendation, this 
symptomatic patient was qualified for ICD implantation [5] 
and additionally, he was advised prompt treatment of any 
fever with antipyretic drugs [3, 5]. Routine DT testing is no 
longer recommended in all patients with ICD and subcu-
taneous electrode implantation may be a useful method 
of lowering DT [6–8].
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Figure 2. Chest X-ray after implantable cardioverter-defibrillator 
(ICD) implantation with additional subcutaneous electrode
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Streszczenie
Zaprezentowano opis przypadku 52-letniego mężczyzny, który po epizodzie omdlenia i bólu w klatce piersiowej trafił do 
szpitala z podejrzeniem ostrego zawału serca z uniesieniem odcinka ST nad ścianą przednią. Pilna koronarografia wy-
kazała prawidłowy obraz tętnic wieńcowych i dopiero zapisy elektrokardiograficzne (EKG) wykonane w kolejnych dobach 
doprowadziły do rozpoznania zespołu Brugadów. Pacjentowi wszczepiono implantowalny kardiowerter-defibrylator, a ze 
względu na wysoki próg defibrylacji konieczne było wszczepienie elektrody podskórnej. Przypadek opisanego pacjenta 
przypomina, że zmiany w EKG w przebiegu zespołu Brugadów mogą naśladować uniesienie odcinka ST w przebiegu 
ostrego zespołu wieńcowego, a podskórna implantacja elektrody może być skuteczną metodą obniżania progu defi-
brylacji.
Słowa kluczowe: zespół Brugadów, implantacja kardiowertera-defibrylatora, próg defibrylacji, elektroda podskórna
Folia Cardiologica 2021; 16, 4: 259–262
References
1. Brugada J, Campuzano O, Arbelo E, et al. Present status of Brugada 
syndrome: JACC state-of-the-art review. J Am Coll Cardiol. 2018; 72(9): 
1046–1059, doi: 10.1016/j.jacc.2018.06.037, indexed in Pubmed: 
30139433.
2. Dybich P, Bąkowski D, Wożakowska-Kapłon B. [Syncope in male — let 
us think about Brugada syndrome! Presentation of 3 cases] [Article 
in Polish]. Kardiol Pol. 2010; 68(12): 1397–400; discussion 1401, 
indexed in Pubmed: 21174301.
3. Rattanawong P, Vutthikraivit W, Charoensri A, et al. Fever-induced Bru-
gada syndrome is more common than previously suspected: a cross-
-sectional study from an endemic area. Ann Noninvasive Electrocar-
diol. 2016; 21(2): 136–141, doi: 10.1111/anec.12288, indexed in 
Pubmed: 26178440.
4. Nademanee K, Hocini M, Haïssaguerre M. Epicardial substrate ab-
lation for Brugada syndrome. Heart Rhythm. 2017; 14(3): 457–461, 
doi: 10.1016/j.hrthm.2016.12.001, indexed in Pubmed: 27979714.
5. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. Task Force for 
the Management of Patients with Ventricular Arrhythmias and the 
Prevention of Sudden Cardiac Death of the European Society of Car-
diology (ESC). 2015 ESC Guidelines for the management of patients 
with ventricular arrhythmias and the prevention of sudden cardiac 
death: the Task Force for the Management of Patients with Ventricu-
lar Arrhythmias and the Prevention of Sudden Cardiac Death of the 
European Society of Cardiology (ESC). Endorsed by: Association for 
European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 
2015; 36(41): 2793–2867, doi: 10.1093/eurheartj/ehv316, indexed 
in Pubmed: 26320108.
6. Hayase J, Do DH, Boyle NG. Defibrillation threshold testing: current 
status. Arrhythm Electrophysiol Rev. 2018; 7(4): 288–293, doi: 
10.15420/aer.2018.54.2, indexed in Pubmed: 30588318.
7. Jacob S, Pidlaoan V, Singh J, et al. High defibrillation threshold: the 
science, signs and solutions. Indian Pacing Electrophysiol J. 2010; 
10(1): 21–39, indexed in Pubmed: 20084193.
8. Kempa M, Lubiński A, Wilczek R, et al. Zastosowanie podskórnej 
elektrody defibrylującej w celu obniżenia progu defibrylacji migotania 
komór u pacjentów z ICD. Folia Cardiol. 2004; 11(6): 463–470.
